EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Earnings Per Share [Abstract]
Net income attributable to Valeant Pharmaceuticals International, Inc.	$ 49.5	$ 275.4	$ 70.2	$ 378.6
Basic weighted-average number of common shares outstanding	344.9	335.4	340.8	335.2
Diluted effect of stock options, RSUs and other (in shares)	6.1	5.9	6.4	6.2
Diluted weighted-average number of common shares outstanding	351.0	341.3	347.2	341.4
Earnings per share attributable to Valeant Pharmaceuticals International, Inc.:
Basic (in usd per share)	$ 0.14	$ 0.82	$ 0.21	$ 1.13
Diluted (in usd per share)	$ 0.14	$ 0.81	$ 0.20	$ 1.11